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ABSTRACT
The allergenic activity of 60 kDa antigen of Brugia
malayi adult worm, due to its ability to release histamine
from mast cells, has been previously reported by us. To
determine the roles of protein kinase C (PKC) and
calmodulin in this process, histamine release from
passively sensitized lung and peritoneal mast cells was
investigated in the presence of W-7 and trifluoperazine,
used as calmodulin inhibitors, and H-7, used as a PKC
inhibitor. The results show that H-7 is able to inhibit
histamine release from both lung and peritoneal mast
cells, thus suggesting a vital role of PKC in histamine
release. However, lung and peritoneal mast cells
exhibited a differential response to the calmodulin
inhibitors. The calmodulin inhibitors prevented
histamine release from peritoneal mast cells, but not
from lung mast cells, thus suggesting that calmodulin is
not essential for histamine release by lung mast cells.
Key words: Brugia malayi, calmodulin, histamine,
lung mast cells, Mastomys natalensis, peritoneal mast
cells, protein kinase C.
INTRODUCTION
Parasite-specific IgE and the release of histamine from
sensitized mast cells by parasite antigens is thought to be
responsible for the clinical manifestations of lymphatic
filariasis, such as lymphadenitis, lymphangitis and
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elephontiosis.' The interaction of parasite antigen with
specific IgE on the cell membrane is responsible for Ca 2+
influx, which transduces extracellular signals into intra-
cellular events by binding with specific proteins, such as
calmodulin (CaM).2 This also stimulates the enzyme
phospholipase C (PLC) to hydrolyse phosphatidyl 1
inositol-4,S, diphosphate to form inositol triphosphate
(IP3) and diacylglycerol (DAG). These products of
phosphoinositide hydrolysis are important second
messengers in cell octivotion.:' Inositol triphosphate is
responsible for the mobilization of intracellular Ca2+. This
increase in intracellular Ca 2+ is required for the activation
of Ca 2+ICaM-dependent protein kinases. Diacylglycerol
also acts as a second messenger by activating protein
kinase C (PKC). Protein phosphorylation catalysed by
these kinases is a prerequisite for the release of granule
contents from mast cells."
However, there are few studies into the mechanisms
involved in histamine release from mast cells during
allergic manifestations of filariasis. In an earlier study, we
demonstrated that the 60 kDa antigen fraction from adult
Brugia malayi is an efficient allergen, as indicated by its
capacity to release histamine from specifically sensitized
mast cells, and it therefore may have an important role in
the pathology of the diseose."
The present study was designed to investigate the roles
of CaM and PKC in the release of histamine from
sensitized mast cells. This was done indirectly by the use of
trifluoperazine (TFP) and (N-6 amino hexyl-1)-S-chloro- 1-
naphthalene sulfonamide (W-7) as calmodulin inhibitors
and 1-S-isoquinolinesulfonyl 1-2 methylpiperazine dihy-
drochloride (H-7) as a PKC inhibitor.
While TFP and W-7 inhibit Ca 2+ICaM-dependent
protein phosphorvlotion.? H-7 inhibits cell activity by
binding to phospholipid-dependent PKC (PLD-PKC).7
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Both lung and peritoneal mast cells (LMC and PMC,
respectively) were obtained and were passively sensitized
with immune serum collected at various time intervals
after infection with B. ma/ayi L3 larvae to highlight the
possible differences in their response. Furthermore,
investigations into the mechanisms involved in the release
of histamine by the 60 kDa antigen fraction may have




Male Mastomys nata/ensis (GRA strain), 3-4 weeks of age,
bred by conventional methods were used in the present
study. Animals were infected subcutaneously with 100 L3
larvae of B. ma/ayi obtained from infected Aedes aegypti
mosquitos. A microfilarial count was performed on 20 mL
blood collected from the tail vein periodically from 90 days
postinfection onwcrds." Blood collected at various times
postinfection from the retro-orbital plexus was used for
serum separation and serum was stored at -70°C till use.
Preparation of crude worm extract antigen
Crude worm extract antigen was prepared essentially as
previously described.? Briefly, B. ma/ayi adult worms
collected from Mastomys were given extensive washing
with phosphate-buffered saline (PBS; pH 7.2). These
worms were lyophilized and suspended in extraction buffer
(50 rnrnol/L HEPES, 100 rnrnol/L glycine, pH 7.2), which
contained phenyl methyl sulphonyl fluoride (2 rnrnol/l.,
Sigma Chemical Co., St Louis, MO, USA), leupeptin (0.2
mmol/L) and EDTA (1 rnrnol/I] as protease inhibitors.
Parasites were homogenized in a hand-held glass tissue
homogenizer. The homogenate was incubated overnight
at 4°C with constant agitation and was then centrifuged at
100 000 9 for 1 h. The supernatant was used as the
antigen after protein estimation.
Characterization and purification of the
60 kDa antigen
The crude worm antigen was separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) in a 4% stacking gel/10% running gel in the
presence of ~-mercaptoethanol.lO
The gel containing the protein corresponding to the 60
kDa antigen, with standard molecular weight markers,
was cut and macerated. This was suspended in PBS (pH
7.2) and dialysed against PBS overnight to remove SDS.
This dialysed material was centrifuged at 10 000 9 for 30
min. The gel-free supernatant was collected and used for
the histamine release assay.
Isolation of mast cells
An enzyme-digested lung tissue cell suspension from
M. nata/ensis was prepared according to the method
described by Fox et 0/. 11 with slight modifications. Lung
tissue was washed twice with PBS (pH 7.2) and was cut
into 2-5 mm pieces. These pieces were washed twice with
50 mL Ca 2 +_M g2+ -free Hank's balanced salt saline
(CMF-HBSS) containing 25 mrnol/L HEPES and 1.3 X
10-4 mol/L EDTA (pH 7.2) to remove epithelial cells. This
was followed by digestion with pronase (2 mg/mL) to
obtain free cells. The residual fragments were mechan-
ically disrupted by repeated syringing. Supernatants from
enzymatic digestion were pooled with cells obtained from
mechanical disruption. The resulting suspension was
rapidly filtered through a 10 mL syringe containing loosely
packed nylon woo/. Cells were washed with CMF-HBSS.
Mast cells thus obtained were further purified by flotation
through a discontinuous Percoll gradient and were
centrifuged at 400 9 for 10 min. The cells found between
the 50 and 70% Percoll interphase were washed twice with
CMF-HBSS.
Mast cells obtained from peritoneal washings with
CMF-HBSS were also washed and purified by Percoll
gradient. The viability of isolated mast cells was checked
with 0.1 % Trypan blue and purity was assessed by
staining with 0.5% Toluidine blue in 0.5 mol/L HC/. The
viability and purity of the cells were> 90%.
Histamine release assay
Both LMC and PMC in HBSS (1-2 X 105 celis/mL) were
pre-incubated at 3JOC for 10 min. Diluted immune
serum in HBSS (2 mL) was added and incubated at 37°C
for 30 min with gentle shaking to keep the cells in
suspension. Mast cells recovered by centrifugation at
300 9 for 8 min were washed twice in HBSS. These cells
were resuspended in HBSS at a concentration of 1 X 10 6
cells/mL and were used for the histamine release ossov.l?
These presensitized cells were challenged with 60 kDa
adult worm antigen (10 Ilg/mL) at 3JOC for 30 min.
Subsequently, 2 mL ice-cold CMF-HBSS was added and
the cell suspension was centrifuged at 400 9 for 10 min.
The supernatant was assayed for histamine release. To
assess total histamine, cells were lysed with 0.3 rnol/L
perchloric acid, centrifuged and the supernatant assayed
for histornine.':'
Released histamine was expressed as a percentage
and calculated as follows:
% Released histamine = Histamine in supernatant X 100
Histamine in supernatant
+ histamine in lysate
In vitro exposure of mast cells to blockers
To study the role of PKC and CaM in the release of
histamine, mast cells were pre-incubated at 37°C for 30
min with various drugs at different concentrations before
being challenged with the crude worm antigen.
Different sets of experiments were performed for each
drug. A cell suspension without drug was taken as the
control.
Preparation of drugs
All drugs were purchased from Sigma Chemical Co.
(St Louis, MO, USA).
Trifluoperazine was dissolved directly in HBSS and the
pH was adjusted to 6.8. A stock solution of W-7 was
prepared in HBSS at pH 2.3 with stirring in the dark at
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room temperature. Finally, the pH was adjusted to 6.8.
A stock solution of H-7 was prepared in dimethyl
sulfoxide (DMSO). Subsequent dilutions of H-7 were
made in HBSS before use. None of the concentrations
of solvents used interfered with the release and assay of
histamine.
Statistical analysis
The results shown are representative data of six
independent experiments. Various parameters were
compared by Student's unpaired t-test.
RESULTS
Serum samples collected at various times postinfection
were used for the sensitization of mast cells before their
activation by 60 kDa parasite antigen. It was found that
serum collected at 5 months postinfection induced
optimum sensitization of both LMC and PMC to release
maximum histamine (Figs 1,2). Hence, this serum was
used for subsequent investigations to determine the role
of various inhibitors in histamine release.
Experiments investigating the inhibitory effect of H-7 on
sensitized mast cells after activation with 60 kDa filarial
antigen indicated that there was a significant decrease in
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Fig. 1 Histamine release from sensitized lung mast cells
after exposure to 60 kDa Brugia malayi adult worm antigen.
Mast cells were passively sensitized with serum collected from
mastomys at various times postinfection and were challenged
with 60 kDa antigen. (e), infected; (0), uninfected control.
Data are the mean ± SD (n = 6). *No significant difference at
the 0.001 level (P > 0.05); **0 significant difference at the
0.001 level (P < 0.001).
Months postinfection
Fig. 2 Histamine release from sensitized peritoneal mast
cells after exposure to 60 kDa antigen of Brugia malayi at
various times postinfection. (e), infected; (0), uninfected
control. Data are the mean ± SD (n = 6). "No significant
difference at the 0.001 level (P > 0.05); **0 significant
difference at the 0.001 level (P < 0.001).
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of H-7 at concentrations as low as 10 11m
(P < 0.001; Figs 3,4).
The histamine release assay was performed in the
presence of W-7 and TFP as CaM inhibitors at an
optimum concentration of 20 urnol/L, It was found that
W-7 significantly reduced histamine released by 60 kDa
antigen (P < 0.001) from PMC at a minimum concen-
tration of 20l1m W-7 (Fig. 5). In contrast, it was
observed that W-7 did not inhibit histamine release from
LMC at the same concentration, indicating differences in
the response by the two cell types in the presence of W-7
(Fig. 6).
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Fig. 5 Inhibition of histamine release in the presence of
W-7. Mast cells were passively sensitized with immune serum
and were incubated with various concentrations of W-7 at
3rc. Subsequently, cells were challenged with 60 kOa
antigen. A cell suspension without W-7 was taken as the
control. (e), infected; (0), control. Results are the mean ± SO.















Fig. 3 Inhibition of histamine release in the presence of H-7.
Mast cells were passively sensitized with immune serum and
were incubated with various concentrations of H-7 at 3rC for
30 min. Subsequently, cells were challenged with 60 kOa
antigen. A cell suspension without H-7 was taken as the
control. (e), infected; (0), control. Results are the mean ± SO
(n = 6). *No significant difference at the 0.05 level (P > 0.05);
**a significant difference at the 0.001 level (P < 0.001).





























Months postinfection Months postinfection
Fig. 4 Comparison of histamine release from lung mast
cells (mI) and peritoneal mast cells (Ii) after exposure to 60
kOa antigen of Brugia ma/ayi in the presence of H-7. Values are
the mean ± SO. *P > 0.05.
Fig. 6 Comparison of histamine release from lung mast
cells (a) and peritoneal mast cells (Ill) after exposure to 60
kOa antigen of Brugia ma/ayi in the presence of W-7. Values
are the mean ± SO; *P > 0.05, **P < 0.001.
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DISCUSSION
Fig. 7 Comparison of histamine release from lung mast
cells (W) and peritoneal mast cells (Ill) after exposure to 60
kDa antigen of Brugia ma/ayi in the presence of trifluoperazine.
Values are the mean ± SD; *P > 0.05, **P < 0.001.
Experiments using TFP showed no inhibition of
histamine release from LMC at the fifth month post-
infection in both test and control. However, there was a
significant inhibition of histamine release in the presence
of TFP (P < 0.001) when experiments were conducted
with PMC. Thus, differences in histamine release between
the two cell types in the presence of TFP were statistically
significant (Fig. 7).
The histamine release assay was performed using two
prototype mast cell populations. Lung mast cells,
belonging to the category of mucosal mast cell (MMC), are
also termed 'atypical mast cells' and PMC, which represent
connective tissue mast cells (CTMC), are termed 'typical
mast cells'. These groups of mast cells differ in various
properties, such as their origin, staining properties, proteo-
glycan contents and T cell dependence. 19 Thus, a parallel
study was conducted, using both types of mast cells, in
order to distinguish any possible differences in the relative
role of these two cell populations in the pathogenesis of
filariasis. However, the results of an in vitro assay system in
the present study cannot be extrapolated to in vivo
conditions, as the sensitization of these mast cells was
performed artificially under in vitro conditions.
The present study was performed with the 60 kDa
parasite antigen at various times postinfection. It was
observed that the 60 kDa antigen induced optimum
histamine release at 5 months postinfection, which was
subsequently used for further studies. It was observed that
H-7, a PLD-PKC inhibitor effectively blocked histamine
release from both LMC and PMC activated with 60 kDa.
This suggested the importance of PLD-PKC in histamine
release. Similarly, Clark et 01.,2° while working with T cells,
demonstrated that H-7 inhibited antigen or interleukin-2-
induced proliferation of T cells. However, the possible
involvement of other PKC, such as cyclic nucleotide
kinases, in the release of histamine from mast cells during
filarial infection cannot be ruled out, as H-7 also inhibits
the activity ofthese PKC in addition to PLD-PKC.
To determine the role of CaM in mast cell activation by
60 kDa antigen, cells were pre-incubated with TFPor W-7
before challenge. There was a variation in the results
obtained for both LMC and PMC in the presence of these
inhibitors. While incubation with CaM antagonists had no
effect on LMC, histamine release was blocked in PMC
after activation with 60 kDa antigen. This suggests that
CaM is a prerequisite for PMC activation in filarial
infection, although the same is not true for LMC. This
further suggests that the relative role of CaM or PLD-PKC
is dependent on the type of cell as well as the nature of the
cell activator. Thus, from the present study, it is apparent
that CaM-dependent PKC and PLD-PKC act through
independent pathways. Similar results were obtained
when Howcraft et a/.21 studied the role of PLD-PKC and
CaM in the lytic activity of primary cytotoxic T lymphocytes
(CTL) by using specific inhibitors, such as H-7 and W-7.
They observed that primary killer activity of CTL required


















Various pharmacological agents have been used to study
the roles of CaM and PKC in cell activation, including
TFP and W-7, which inhibit Ca 2+ICaM-dependent
protein phcsphorvlotion.e":" and H-7, which inhibits
cell activity by binding to PLD-PKC.7 The specific
inhibitory activity of H-7 of PLD-PKC has also been used
by others to demonstrate the role of PLD-PKC in the
phosphorylation of proteins.Pl" The activation of mast
cells by parasite antigen in the presence of these drugs
helps to investigate the activity of PLD-PKC or CaM and,
hence, their roles in mast cell activation. Although
various methods are available for the direct measure-
ment of PKC and CaM after their extraction from the cell
source using specific substrates, these methods are
expensive and tedious to perform. Because in the present
study histamine release was taken as a marker of mast
cell activation, specific drugs were used to inhibit hista-
mine release and to establish the roles of PLD-PKC and
CaM in mast cell activation by parasite antigens.
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whereas highly lytic cultured T cells required only CaM for
cell activation. Similarly, H-7 failed to inhibit the res-
piratory burst activity and secretory response of stimulated
neutrophils, whereas W-7 completely blocked neutrophil
cctivction.i? Therefore, it is possible that a synergistic
action between DAG, which activates through PLD-PKC,3
and higher cytosolic Ca 2+, which acts through CaM, may
be operating in mast cells.23
Thus, it can be concluded from the present study that
CaM-dependent pathways are not essential for LMC
activation, although they are absolutely essential for PMC
activation by the 60 kDa antigen of B. ma/ayi. However,
PLD-PKC is an essential requirement for both populations
of mast cells as has already been demonstrated in rat
mast cells." Further studies are needed to correlate these
in vitro findings to the in vivo situation in order to
understand the role of these biochemical pathways in the
pathogenesis of filariasis.
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